J.P. Morgan Securities PLC, a Class (5) associate connected with the Offeror and ultimately owned by JPMorgan Chase & Co., has disclosed multiple transactions involving derivatives linked to Kangji Medical Holdings Ltd. On 23 October 2025, J.P. Morgan Securities PLC closed out derivative contracts relating to 494, 23,500, 1,499, and 13,000 reference securities, and issued a derivative contract relating to 38,500 reference securities with a maturity date of 25 November 2026. Additionally, a derivative contract relating to 1,500 reference securities was closed out with a maturity date of 24 September 2027. All dealings were made for J.P. Morgan Securities PLC's own account.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kangji Medical Holdings Ltd. published the original content used to generate this news brief on October 24, 2025, and is solely responsible for the information contained therein.